Artículos por temáticas

Blood films in the investigation of chorea.

Alawneh J, Baker MR, Young GR.

Pract Neurol. 2012 Aug;12(4):268. doi: 10.1136/practneurol-2012-000287. No abstract available.

Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset?

Vogel AP, Shirbin C, Churchyard AJ, Stout JC.

Neuropsychologia. 2012 Dec;50(14):3273-8. doi: 10.1016/j.neuropsychologia.2012.09.011.

Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.

Enzi B, Edel MA, Lissek S, Peters S, Hoffmann R, Nicolas V, Tegenthoff M, Juckel G, Saft C.

Exp Neurol. 2012 May;235(1):256-64. doi: 10.1016/j.expneurol.2012.02.003.

Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Ju TC, Lin YS, Chern Y.

Cell Mol Life Sci. 2012 Dec;69(24):4107-20. doi: 10.1007/s00018-012-1025-2. Review.

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.

Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC

PLoS One. 2012;7(12):e49838. doi: 10.1371/journal.pone.0049838.

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.

Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta JA.

Mol Cell Neurosci. 2012 Mar;49(3):271-81. doi: 10.1016/j.mcn.2011.12.001.

Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease.

Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du XJ.

J Physiol. 2012 Nov 15;590(22):5845-60. doi: 10.1113/jphysiol.2012.238113.

Making sense out of antisense in Huntington's disease.

Skaper SD.

CNS Neurol Disord Drug Targets. 2012 Sep;11(6):647-8. No abstract available.

Neurodegenerative disease: Establishing a clinical trial battery for Huntington disease.

Paulsen JS, Long JD.

Nat Rev Neurol. 2012 Apr 10;8(5):250-1. doi: 10.1038/nrneurol.2012.67. No abstract available.

The search for sensitive biomarkers in presymptomatic Huntington disease.

Henry PG, Mochel F.

J Cereb Blood Flow Metab. 2012 May;32(5):769-70. doi: 10.1038/jcbfm.2012.17. Review. No abstract available.

Implicit contextual learning in prodromal and early stage Huntington's disease patients.

van Asselen M, Almeida I, Júlio F, Januário C, Campos EB, Simões M, Castelo-Branco M.

J Int Neuropsychol Soc. 2012 Jul;18(4):689-96. doi: 10.1017/S1355617712000288.

[Is Huntington's disease a neurological or psychiatric disorder? case report].

Dubas-Slemp H, Tylec A, Michałowska-Marmurowska H, Spychalska K.

Psychiatr Pol. 2012 Sep-Oct;46(5):915-22. Review. Polish.

Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.

Chen S, Lu FF, Seeman P, Liu F.

Neurochem Res. 2012 Dec;37(12):2805-13. doi: 10.1007/s11064-012-0874-2.

Assessment of cortical and striatal involvement in 523 Huntington disease brains.

Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH, Vonsattel JP.

Neurology. 2012 Oct 16;79(16):1708-15. doi: 10.1212/WNL.0b013e31826e9a5d.

Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.

Clay E, De Nicola A, Dorey J, Squitieri F, Aballéa S, Martino T, Tedroff J, Zielonka D, Auquier P, Verny C, Toumi M.

Int Clin Psychopharmacol. 2012 Jul;27(4):208-14. doi: 10.1097/YIC.0b013e3283534fa9.